 Foster Goss
Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 24 | 2025 | 975 | 3.430 |
Why?
| | Drug Hypersensitivity | 10 | 2025 | 81 | 1.860 |
Why?
| | Documentation | 9 | 2022 | 184 | 1.840 |
Why?
| | Speech Recognition Software | 4 | 2020 | 11 | 1.800 |
Why?
| | Medical Errors | 3 | 2019 | 104 | 1.600 |
Why?
| | Hypersensitivity | 6 | 2025 | 249 | 1.330 |
Why?
| | Vocabulary, Controlled | 4 | 2018 | 45 | 1.130 |
Why?
| | Speech | 2 | 2019 | 74 | 1.100 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 6 | 2022 | 253 | 0.980 |
Why?
| | Emergency Service, Hospital | 6 | 2021 | 1902 | 0.970 |
Why?
| | Natural Language Processing | 5 | 2018 | 94 | 0.810 |
Why?
| | Medical Order Entry Systems | 5 | 2025 | 43 | 0.790 |
Why?
| | Point-of-Care Systems | 1 | 2021 | 147 | 0.630 |
Why?
| | Decision Support Systems, Clinical | 6 | 2025 | 205 | 0.630 |
Why?
| | Drug Prescriptions | 1 | 2021 | 248 | 0.620 |
Why?
| | Medical Records | 1 | 2018 | 171 | 0.570 |
Why?
| | Firearms | 1 | 2022 | 359 | 0.510 |
Why?
| | Uterine Artery Embolization | 1 | 2014 | 6 | 0.470 |
Why?
| | Uterine Hemorrhage | 1 | 2014 | 33 | 0.460 |
Why?
| | Arteriovenous Malformations | 1 | 2014 | 27 | 0.460 |
Why?
| | Uterus | 1 | 2014 | 207 | 0.420 |
Why?
| | Health Personnel | 1 | 2019 | 652 | 0.420 |
Why?
| | Adverse Drug Reaction Reporting Systems | 4 | 2022 | 74 | 0.400 |
Why?
| | Medication Errors | 4 | 2025 | 95 | 0.400 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 2012 | 48 | 0.380 |
Why?
| | Ticlopidine | 1 | 2012 | 54 | 0.380 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 2012 | 140 | 0.370 |
Why?
| | Thiophenes | 1 | 2012 | 118 | 0.370 |
Why?
| | Boston | 3 | 2020 | 87 | 0.350 |
Why?
| | Piperazines | 1 | 2012 | 342 | 0.320 |
Why?
| | Terminology as Topic | 3 | 2015 | 204 | 0.310 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2012 | 442 | 0.290 |
Why?
| | Systematized Nomenclature of Medicine | 3 | 2018 | 13 | 0.280 |
Why?
| | Humans | 34 | 2025 | 129650 | 0.280 |
Why?
| | Information Storage and Retrieval | 2 | 2021 | 108 | 0.280 |
Why?
| | Penicillins | 2 | 2025 | 57 | 0.270 |
Why?
| | Physicians | 3 | 2020 | 865 | 0.240 |
Why?
| | Medication Reconciliation | 1 | 2025 | 29 | 0.240 |
Why?
| | Medical History Taking | 1 | 2025 | 119 | 0.230 |
Why?
| | Cephalosporins | 1 | 2025 | 40 | 0.230 |
Why?
| | Food Hypersensitivity | 2 | 2017 | 176 | 0.210 |
Why?
| | Analgesics, Opioid | 2 | 2025 | 913 | 0.210 |
Why?
| | Workflow | 2 | 2019 | 155 | 0.170 |
Why?
| | Medical Records Systems, Computerized | 2 | 2018 | 93 | 0.170 |
Why?
| | Massive Hepatic Necrosis | 1 | 2019 | 3 | 0.160 |
Why?
| | Biological Ontologies | 1 | 2019 | 18 | 0.160 |
Why?
| | Hepatitis A | 1 | 2019 | 25 | 0.160 |
Why?
| | Allergens | 5 | 2022 | 385 | 0.160 |
Why?
| | Speech Perception | 1 | 2020 | 83 | 0.150 |
Why?
| | Community Health Planning | 1 | 2018 | 42 | 0.150 |
Why?
| | Clinical Audit | 1 | 2018 | 11 | 0.150 |
Why?
| | Travel | 1 | 2019 | 122 | 0.150 |
Why?
| | Datasets as Topic | 1 | 2018 | 110 | 0.140 |
Why?
| | Female | 14 | 2025 | 68776 | 0.140 |
Why?
| | Algorithms | 1 | 2025 | 1622 | 0.140 |
Why?
| | Linguistics | 1 | 2017 | 27 | 0.130 |
Why?
| | Drug Therapy, Computer-Assisted | 2 | 2015 | 10 | 0.130 |
Why?
| | Perception | 1 | 2019 | 340 | 0.130 |
Why?
| | Models, Theoretical | 2 | 2020 | 547 | 0.130 |
Why?
| | Consensus | 1 | 2019 | 616 | 0.130 |
Why?
| | Pharmacovigilance | 1 | 2015 | 21 | 0.130 |
Why?
| | Anaphylaxis | 1 | 2017 | 98 | 0.130 |
Why?
| | Databases as Topic | 1 | 2015 | 59 | 0.120 |
Why?
| | Cross-Sectional Studies | 4 | 2025 | 5066 | 0.120 |
Why?
| | Middle Aged | 7 | 2025 | 31154 | 0.120 |
Why?
| | Word Processing | 1 | 2015 | 1 | 0.120 |
Why?
| | Ambulatory Care | 1 | 2019 | 504 | 0.120 |
Why?
| | Male | 12 | 2025 | 63681 | 0.120 |
Why?
| | Clinical Alarms | 1 | 2015 | 10 | 0.120 |
Why?
| | Data Accuracy | 1 | 2015 | 57 | 0.120 |
Why?
| | Adult | 6 | 2025 | 35576 | 0.110 |
Why?
| | User-Computer Interface | 3 | 2025 | 149 | 0.110 |
Why?
| | Physician's Role | 1 | 2016 | 206 | 0.110 |
Why?
| | Aged | 4 | 2025 | 22103 | 0.110 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 1098 | 0.100 |
Why?
| | Social Media | 1 | 2016 | 137 | 0.100 |
Why?
| | Diffusion of Innovation | 1 | 2013 | 97 | 0.100 |
Why?
| | Quality Assurance, Health Care | 1 | 2015 | 318 | 0.100 |
Why?
| | Aspirin | 1 | 2016 | 380 | 0.100 |
Why?
| | Tertiary Care Centers | 1 | 2013 | 151 | 0.100 |
Why?
| | Incidence | 2 | 2016 | 2644 | 0.100 |
Why?
| | Prasugrel Hydrochloride | 1 | 2012 | 22 | 0.100 |
Why?
| | Cytochrome P-450 CYP2C19 | 1 | 2012 | 23 | 0.100 |
Why?
| | Microcomputers | 1 | 2012 | 16 | 0.100 |
Why?
| | Sex Factors | 1 | 2017 | 1968 | 0.090 |
Why?
| | Aged, 80 and over | 2 | 2018 | 7086 | 0.080 |
Why?
| | Emergency Medicine | 1 | 2012 | 215 | 0.080 |
Why?
| | Colorado | 1 | 2018 | 4421 | 0.070 |
Why?
| | Massachusetts | 2 | 2020 | 159 | 0.070 |
Why?
| | Reference Standards | 2 | 2019 | 177 | 0.070 |
Why?
| | Opioid-Related Disorders | 1 | 2015 | 484 | 0.070 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 5406 | 0.070 |
Why?
| | Patient Care Team | 1 | 2012 | 605 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2742 | 0.070 |
Why?
| | Prevalence | 3 | 2018 | 2564 | 0.070 |
Why?
| | Follow-Up Studies | 1 | 2014 | 4897 | 0.060 |
Why?
| | Risk Assessment | 1 | 2014 | 3240 | 0.060 |
Why?
| | Hypoglycemic Agents | 1 | 2012 | 1220 | 0.050 |
Why?
| | United States | 4 | 2019 | 13903 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2014 | 10230 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2025 | 14518 | 0.040 |
Why?
| | Peru | 1 | 2019 | 53 | 0.040 |
Why?
| | Hypersensitivity, Delayed | 1 | 2018 | 28 | 0.040 |
Why?
| | Pilot Projects | 2 | 2016 | 1587 | 0.040 |
Why?
| | Hypersensitivity, Immediate | 1 | 2018 | 43 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2019 | 300 | 0.040 |
Why?
| | Radioallergosorbent Test | 1 | 2017 | 3 | 0.040 |
Why?
| | Shellfish | 1 | 2017 | 6 | 0.040 |
Why?
| | Musculoskeletal Pain | 1 | 2016 | 34 | 0.030 |
Why?
| | Data Mining | 1 | 2017 | 110 | 0.030 |
Why?
| | Immunoglobulin E | 1 | 2017 | 329 | 0.030 |
Why?
| | Exanthema | 1 | 2016 | 74 | 0.030 |
Why?
| | Meaningful Use | 1 | 2015 | 13 | 0.030 |
Why?
| | Publishing | 1 | 2017 | 140 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 894 | 0.030 |
Why?
| | Utilization Review | 1 | 2015 | 36 | 0.030 |
Why?
| | Risk | 1 | 2017 | 854 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1214 | 0.030 |
Why?
| | Drug Interactions | 1 | 2015 | 394 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2016 | 171 | 0.030 |
Why?
| | Language | 1 | 2017 | 283 | 0.030 |
Why?
| | Medication Systems, Hospital | 1 | 2012 | 9 | 0.030 |
Why?
| | China | 1 | 2013 | 191 | 0.030 |
Why?
| | Population Surveillance | 1 | 2016 | 439 | 0.030 |
Why?
| | Time and Motion Studies | 1 | 2012 | 21 | 0.020 |
Why?
| | Clinical Decision-Making | 1 | 2015 | 303 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1269 | 0.020 |
Why?
| | Machine Learning | 1 | 2015 | 443 | 0.020 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2012 | 248 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2535 | 0.020 |
Why?
| | Hospitalization | 1 | 2015 | 2070 | 0.020 |
Why?
| | Risk Factors | 1 | 2015 | 9765 | 0.010 |
Why?
| | Prospective Studies | 1 | 2012 | 7133 | 0.010 |
Why?
| | Adolescent | 1 | 2015 | 20393 | 0.010 |
Why?
|
|
Goss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|